“…The minimum efficient doses (MED) of BP-C2 showing radiomitigative effects in murine animal models range from 35mg/kg (mouse, topical) to 81mg/kg (mouse, oral) or 93.7mg/kg (rat, oral). The MED of BP-C2 protecting bone marrow, blood and liver cells of Balb/c mice from cyclophosphamide and dioxidine is 60mg/kg [5].…”